Geode Capital Management
CLSD icon

Geode Capital Management’s Clearside Biomedical CLSD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$632K Sell
790,373
-1,874
-0.2% -$1.5K ﹤0.01% 3477
2025
Q1
$727K Buy
792,247
+28,189
+4% +$25.9K ﹤0.01% 3411
2024
Q4
$726K Buy
764,058
+32,672
+4% +$31K ﹤0.01% 3482
2024
Q3
$929K Buy
731,386
+59,089
+9% +$75.1K ﹤0.01% 3379
2024
Q2
$874K Buy
672,297
+30,084
+5% +$39.1K ﹤0.01% 3356
2024
Q1
$983K Buy
642,213
+151,523
+31% +$232K ﹤0.01% 3363
2023
Q4
$574K Hold
490,690
﹤0.01% 3556
2023
Q3
$427K Sell
490,690
-8,517
-2% -$7.41K ﹤0.01% 3663
2023
Q2
$559K Sell
499,207
-30,890
-6% -$34.6K ﹤0.01% 3598
2023
Q1
$551K Hold
530,097
﹤0.01% 3606
2022
Q4
$593K Buy
530,097
+4,790
+0.9% +$5.36K ﹤0.01% 3585
2022
Q3
$593K Buy
525,307
+1,316
+0.3% +$1.49K ﹤0.01% 3636
2022
Q2
$770K Buy
523,991
+34,062
+7% +$50.1K ﹤0.01% 3537
2022
Q1
$1.12M Buy
489,929
+3,287
+0.7% +$7.52K ﹤0.01% 3566
2021
Q4
$1.34M Hold
486,642
﹤0.01% 3567
2021
Q3
$2.92M Buy
486,642
+63,101
+15% +$378K ﹤0.01% 3195
2021
Q2
$2.06M Buy
423,541
+58,818
+16% +$286K ﹤0.01% 3261
2021
Q1
$900K Buy
364,723
+38,528
+12% +$95.1K ﹤0.01% 3598
2020
Q4
$893K Hold
326,195
﹤0.01% 3398
2020
Q3
$502K Hold
326,195
﹤0.01% 3429
2020
Q2
$613K Hold
326,195
﹤0.01% 3300
2020
Q1
$554K Buy
326,195
+50,160
+18% +$85.2K ﹤0.01% 3247
2019
Q4
$800K Buy
276,035
+30,856
+13% +$89.4K ﹤0.01% 3353
2019
Q3
$154K Sell
245,179
-809
-0.3% -$508 ﹤0.01% 3854
2019
Q2
$239K Sell
245,988
-73,602
-23% -$71.5K ﹤0.01% 3740
2019
Q1
$441K Buy
319,590
+16,078
+5% +$22.2K ﹤0.01% 3480
2018
Q4
$324K Buy
303,512
+14,181
+5% +$15.1K ﹤0.01% 3526
2018
Q3
$1.78M Buy
289,331
+14,290
+5% +$87.9K ﹤0.01% 2951
2018
Q2
$2.94M Buy
275,041
+32,202
+13% +$344K ﹤0.01% 2624
2018
Q1
$2.61M Buy
242,839
+112,992
+87% +$1.21M ﹤0.01% 2623
2017
Q4
$908K Buy
129,847
+3,761
+3% +$26.3K ﹤0.01% 3139
2017
Q3
$1.1M Buy
126,086
+3,001
+2% +$26.2K ﹤0.01% 3080
2017
Q2
$1.12M Buy
123,085
+26,761
+28% +$244K ﹤0.01% 3056
2017
Q1
$764K Buy
96,324
+5,596
+6% +$44.4K ﹤0.01% 3140
2016
Q4
$811K Buy
90,728
+48,653
+116% +$435K ﹤0.01% 3092
2016
Q3
$730K Buy
+42,075
New +$730K ﹤0.01% 3097